Causes of gastrointestinal bleeding in oral anticoagulant users compared to non-users in a population-based study

Causes of gastrointestinal bleeding (GIB) in patients on oral anticoagulants (OACs) are not well established. The aims of the study were to compare the causes of GIB in patients on OACs and those not on OAC therapy. A nationwide study of all GIB events in patients on OACs in Iceland from 2014–2019 w...

Full description

Bibliographic Details
Main Authors: Ágústsson, Arnar S., Ingason, Arnar B., Rumba, Edward, Pálsson, Daníel, Reynisson, Indriði E., Hreinsson, Jóhann P., Björnsson, Einar S.
Format: Other Non-Article Part of Journal/Newspaper
Language:unknown
Published: Taylor & Francis 2021
Subjects:
Pharmacology
59999 Environmental Sciences not elsewhere classified
FOS Earth and related environmental sciences
39999 Chemical Sciences not elsewhere classified
FOS Chemical sciences
Ecology
FOS Biological sciences
Cancer
110309 Infectious Diseases
FOS Health sciences
Iceland
Online Access:https://dx.doi.org/10.6084/m9.figshare.16960909.v1
https://tandf.figshare.com/articles/journal_contribution/Causes_of_gastrointestinal_bleeding_in_oral_anticoagulant_users_compared_to_non-users_in_a_population-based_study/16960909/1
Description
Summary:Causes of gastrointestinal bleeding (GIB) in patients on oral anticoagulants (OACs) are not well established. The aims of the study were to compare the causes of GIB in patients on OACs and those not on OAC therapy. A nationwide study of all GIB events in patients on OACs in Iceland from 2014–2019 was conducted. Bleeding events were obtained through ICD-10 codes and review of endoscopy databases, confirmed by review of medical records. For comparison, patients not on OACs from previous Icelandic population-based studies were used. Among 752 GIB events in 12,005 patients on OACs, 273 (1.9%) had verified upper and 391 (2.7%) had verified lower GIB. For lower GIB, multivariate analysis showed that OAC users were more likely to have colonic polyps (OR 6.6, 95% CI: 2.4 − 17.8, p p p p p = .003) were more common in OAC users. A high proportion of GIB caused by colonic polyps and colorectal cancer among OAC patients indicates that OACs treatment may facilitate cancer diagnosis. The low proportion of ischemic colitis among those on OACs suggests that OACs provide a protective effect against ischemic colitis. OACs seem to increase the bleeding from angiodysplasia and mucosal erosive disease.

Similar Items